[PDF] mja.com.au

[PDF][PDF] Clinical presentation and management of COVID-19

I Thevarajan, KL Buising, BC Cowie - Med J Aust, 2020 - mja.com.au
The rapid spread severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to
the declaration of a global pandemic barely three months after emerging.• A majority of …
被引用次数：94 相关文章 所有 10 个版本
[HTML] frontiersin.org

[HTML][HTML] Current understanding of COVID-19 clinical course and investigational treatments

RB Aguilar, P Hardigan, B Mayi, D Sider… - Frontiers in …, 2020 - frontiersin.org
Importance: Currently, there is no unified framework linking disease progression to
established viral levels, clinical tests, inflammatory markers, and investigational treatment …
被引用次数：47 相关文章 所有 11 个版本
[PDF] tandfonline.comFull View

COVID-19 treatments approved in the European Union and clinical recommendations for the management of non-hospitalized and hospitalized patients

S Bellino - Annals of medicine, 2022 - Taylor & Francis
Background The COVID-19 pandemic caused by SARS-CoV-2 continues to have a serious
impact on public health worldwide. Most patients develop mild to moderate symptoms and …
被引用次数：23 相关文章 所有 6 个版本
[HTML] nih.gov

[HTML][HTML] A narrative review of COVID-19: the new pandemic disease

K Shirani, E Sheikhbahaei, Z Torkpour… - Iranian Journal of …, 2020 - ncbi.nlm.nih.gov
Nearly every 100 years, humans collectively face a pandemic crisis. After the Spanish flu,
now the world is in the grip of coronavirus disease 2019 (COVID-19). First detected in 2019 …
被引用次数：57 相关文章 所有 14 个版本
[HTML] sciencedirect.com

[HTML][HTML] Recent advances in management of COVID-19: A review

S Mouffak, Q Shubbar, E Saleh, R El-Awady - Biomedicine & …, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused and is still causing
significant mortality and economic consequences all over the globe. As of today, there are …
被引用次数：99 相关文章 所有 6 个版本
[HTML] nih.gov

[HTML][HTML] Medical management of COVID-19: evidence and experience

S Bose, S Adapa, NR Aeddula, S Roy… - Journal of clinical …, 2020 - ncbi.nlm.nih.gov
Coronavirus disease 2019 is caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), and this infectious disease is termed COVID-19 in short. On a global scale …
被引用次数：54 相关文章 所有 11 个版本
[HTML] mdpi.com

[HTML][HTML] Clinical management of COVID-19: a review of pharmacological treatment options

AM Heustess, MA Allard, DK Thompson, PS Fasinu - Pharmaceuticals, 2021 - mdpi.com
Since the outbreak and subsequent declaration of COVID-19 as a global pandemic in March
2020, concerted efforts have been applied by the scientific community to curtail the spread of …
被引用次数：37 相关文章 所有 10 个版本
[HTML] nih.gov

[HTML][HTML] Potential treatments for COVID-19; a narrative literature review

A Rismanbaf - Archives of academic emergency medicine, 2020 - ncbi.nlm.nih.gov
SARS-CoV-2 is a newly emerging human infectious coronavirus that causes COVID-19,
which has been recognized as a pandemic by the World Health Organization (WHO) on …
被引用次数：181 相关文章 所有 18 个版本
[HTML] nih.gov

[HTML][HTML] Current treatment in COVID-19 disease: a rapid review

M Rodriguez-Guerra, P Jadhav, TJ Vittorio - Drugs in context, 2021 - ncbi.nlm.nih.gov
The world has faced the most challenging pandemic of the modern era, that of severe acute
respiratory syndrome coronavirus 2 infection, causing coronavirus disease and affecting …
被引用次数：78 相关文章 所有 6 个版本
[PDF] persi.or.id

[PDF][PDF] COVID-19: interim guidance on management pending empirical evidence

KC Wilson, SH Chotirmall, C Bai, J Rello - From an American thoracic …, 2020 - persi.or.id
COVID‐19: Interim Guidance on Management Pending Empirical Evidence. From an American
Thoracic Society‐led Int Page 1 1 Updated April 3, 2020 COVID‐19: Interim Guidance on …
被引用次数：57 相关文章 所有 3 个版本